Cargando…

Does Rubella Immunity Predict Measles Immunity? A Serosurvey of Pregnant Women

Background. This study was undertaken to determine whether rubella immunity infers measles immunity in pregnant women. Methods. Stored serum samples were obtained from the Iowa State Hygienic Laboratory for evaluation of rubella and measles immunities with IgG enzyme-linked immunosorbent assay. Resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Colleen M., Burns, Barbara A., Ault, Kevin A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581459/ https://www.ncbi.nlm.nih.gov/pubmed/17485795 http://dx.doi.org/10.1155/IDOG/2006/13890

Ejemplares similares

How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2020)

Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers
por: Trevisan, Andrea, et al.
Publicado: (2021)

Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018)

Rubella Serosurvey Among Future Healthcare Workers
por: Trevisan, Andrea, et al.
Publicado: (2021)

Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy
por: Boattini, Matteo, et al.
Publicado: (2019)

Evaluation of Rubella Immunity in a Community Prenatal Clinic
por: Nwanegbo, Edward C., et al.
Publicado: (2013)

Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey
por: Hayford, Kyla, et al.
Publicado: (2019)

Mass Measles Rubella Immunization Campaign: Bhutan Experience
por: Giri, Bhakta R, et al.
Publicado: (2011)

Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees
por: Ezeji-Okoye, Stephen, et al.
Publicado: (2021)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign
por: Honarvar, Behnam, et al.
Publicado: (2013)

Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023)

COVID-19 immune response in adults post Measles-Rubella vaccination
por: Suwoyo, Suwoyo, et al.
Publicado: (2023)

Rubella Immune Status in Pregnant Women in a Northern Mexican City
por: Alvarado-Esquivel, Cosme, et al.
Publicado: (2016)

Rubella Immunity among Pregnant Women in Jeddah, Western Region of Saudi Arabia
por: Alsibiani, Sharifa A.
Publicado: (2014)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Seroprevalence of Toxoplasma, Rubella, and Cytomegalovirus among pregnant women in Van
por: Parlak, Mehmet, et al.
Publicado: (2015)

Measles Serosurveys: A Solution in Search of the Right Problem
por: Ariyarajah, Archchun, et al.
Publicado: (2021)

Do adolescents need a rubella vaccination campaign? Rubella serosurvey among healthy children in Hangzhou, China
por: Wang, Xiaozhen, et al.
Publicado: (2023)

Measles-Rubella Supplementary Immunization Activity Readiness Assessment — India, 2017–2018
por: Gurnani, Vandana, et al.
Publicado: (2018)

Prevalence of Inadequate Immunity to Measles, Mumps, Rubella, and Varicella in MLB and NBA Athletes
por: Conway, Justin J., et al.
Publicado: (2018)

Rubella Immunity in Pregnant Iranian Women: A Systematic Review and Meta-Analysis
por: Azami, Milad, et al.
Publicado: (2019)

The seroprevalence of Rubella in pregnant women in Turkey: a meta-analysis research of 90988 Rubella IgM, 84398 Rubella IgG, and 522 avidity results
por: Çetinkaya, Rıza Aytaç, et al.
Publicado: (2019)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010()
por: Jonas, Anna, et al.
Publicado: (2016)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Low Immunity to Measles and Rubella among Female Guest Workers, Northern Mariana Islands
por: Stambos, Vicki, et al.
Publicado: (2009)

Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh
por: Uddin, Md Jasim, et al.
Publicado: (2016)

Influence of Sociodemographic Factors in Measles-Rubella Campaign Compared with Routine Immunization at Mysore City
por: Joe, Prathyusha, et al.
Publicado: (2019)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020
por: Murhekar, Manoj V, et al.
Publicado: (2022)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Measles and rubella elimination: protecting children through immunization in South-East Asia Region (SEAR)
por: Bahl, Sunil, et al.
Publicado: (2023)

Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space
por: Carcelen, Andrea C., et al.
Publicado: (2022)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
por: Adigweme, Ikechukwu, et al.
Publicado: (2022)

Auto-immune thrombocytopenia after Measles Mumps Rubella MMR vaccination: molecular mimicry of measles virus phosphoprotein with platelet gpIIb
por: Tran, Guy Mong Ky, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qpn1b0c4kkb8bo1udvd9o21f4b